Quick Answer
NewGenIvf Group Ltd reported Operating Income Loss of -$10.73 million for the year ending 2025.
- NewGenIvf Group Ltd showed a decrease of -824.3% in Operating Income Loss from 2024 to 2025.
- This data is from NewGenIvf Group Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), NewGenIvf Group Ltd's Operating Income Loss has declined by 5,496.7%.
- Historical annual values: Fiscal year 2025: -$10.73 million | Fiscal year 2024: -$1.16 million | Fiscal year 2023: $42.2 thousand | Fiscal year 2022: $398.7 thousand | Fiscal year 2021: $198.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: